MARKET

WVE

WVE

Wave Life Scienc
NASDAQ
7.95
+0.25
+3.25%
After Hours: 8.29 +0.34 +4.28% 17:31 07/10 EDT
OPEN
7.73
PREV CLOSE
7.70
HIGH
8.13
LOW
7.56
VOLUME
2.57M
TURNOVER
--
52 WEEK HIGH
16.74
52 WEEK LOW
5.04
MARKET CAP
1.24B
P/E (TTM)
-9.6049
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 1h ago
Wave Life Sciences: Upgrading Rating To Buy After Turbulent 10 Months
Seeking Alpha · 3d ago
Weekly Report: what happened at WVE last week (0630-0704)?
Weekly Report · 3d ago
Wave Life Sciences: Speculative, But Promising
Seeking Alpha · 3d ago
Wave Life Sciences: Promising RNA Editing Developments and Positive Stock Outlook
TipRanks · 6d ago
Weekly Report: what happened at WVE last week (0623-0627)?
Weekly Report · 06/30 09:47
Wave Life Sciences’ WVE-007: Undervalued Potential in Obesity Treatment with Promising Preclinical Results
TipRanks · 06/27 10:49
Where WAVE Life Sciences Stands With Analysts
Benzinga · 06/23 14:01
More
About WVE
Wave Life Sciences Ltd. is a biotechnology company. The Company is focused on unlocking the potential of RNA medicines (oligonucleotides), or those targeting ribonucleic acid (RNA), to transform human health. Its RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing and RNA interference (RNAi), providing Company with capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program in obesity. These programs include WVE-N531, WVE-006 and WVE-003. It is also building a pipeline of novel A-to-I RNA editing oligonucleotides (AIMers).

Webull offers Wave Life Sciences Ltd stock information, including NASDAQ: WVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WVE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WVE stock methods without spending real money on the virtual paper trading platform.